GliXogen Therapeutics
Edit

GliXogen Therapeutics

http://www.futurx.co.il/
Last activity: 03.07.2022
Active
Categories: CartInvestmentManufacturingMedtechScienceTechnology
Followers
133
Mentions
11
Employees: 11-50
Founded date: 2014

Investors 3

Mentions in press and media 11

DateTitleDescription
02.09.2021Куда идти стартапам в ИзраилеСодержание: Бизнес-климат в Израиле Фонды, бизнес-ангелы и другие источники финансирования Локальные акселераторы Самые востребованные ниши Главные университеты Подготовка к выходу на рынок Мероприятия и медиа для предпринимателей Бизнес-со...
13.11.2019ProteKt Therapeutics Secures $3.6M in FinancingProteKt Therapeutics, a Ness Ziona, Israel-based biotech company developing new PKR kinase inhibitor-based therapies for neurodegenerative diseases including Alzheimer’s Disease, raised $US 3.6m in equity financing. The round was co-led by ...
28.06.2017Mitoconix Bio Raises $20M in Series A FundingMitoconix Bio Ltd., a Ness Ziona, Israel-based biopharmaceutical company focused on therapies for neurological diseases, secured a $20m round of Series A funding. The round was led by Remiges Ventures with participation from OrbiMed, Dement...
19.05.2017In a busy field, biotech incubators are evolvingBut in 2017, there is cause to look again. Biotech incubators are evolving and maturing. New models continue to crop up (accelerators, aggregators, commercialization spaces) and existing ones are being refined. As it happens, two notable up...
16.05.2017Israeli digital health incubator has made first investment since launchThe Israeli digital health incubator also recently held a competition to select two more startups for its portfolio. Pending a due diligence review, it is considering a company focused on food allergies and another with a connected cap for ...
23.05.2016OrbiMed launches second fund targeting Israeli biotech, health tech investmentsSo far it has made three investments from OrbiMed Israel Partners II in the past few months: Gene therapy company, logicBio; digital health company focused on protecting patient data in the context of medical research, MDClone; and a gene e...
01.09.2015U.S. investors with keen interest in digital health move into Israel’s incubator landscapeIn a phone interview with MedCity News, Tom Sudow, the director of business development for Cleveland Clinic Global Cardiovascular Innovation Center, said said it fell in love with the Intendu management team, led by Dr Son Preminger. She p...
-OrbiMed launches second fund targeting Israeli biotech, health tech investmentshas launched a $307 million venture capital fund five years after its inagural $202 million fund investing in biotech, diagnostic and medical device and digital health companies. OrbiMed Israel Partners I invested in 28 companies. Merck acq...
-Israeli digital health incubator has made first investment since launchOne year after eHealth Ventures secured a tender from the Office of the Chief Scientist in Israel to run a digital health incubator, it’s got one portfolio business and is reviewing two more, according to Tom Sudow, director of business dev...
-In a busy field, biotech incubators are evolvingBiotech incubators are the quinoa of the life sciences. Five-or-so years ago, they were all the rage. And while we still value what they do (economically/nutritionally), the widespread enthusiasm has waned. They became a regular part of the...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In